Recent developments in the biology and medicinal chemistry of potassium channel modulators: update from a decade of progress.
Coghlan
M J
MJ
Neurological and Urological Diseases Research, Pharmaceutical Products Division, Abbott Laboratories, 100 Abbott Park Road, Abbott Park, Illinois 60064, USA. michael.j.coghlan@abbott.com
Carroll
W A
WA
Gopalakrishnan
M
M
D000255:Adenosine Triphosphate / Q000502:physiology; D000787:Angina Pectoris / Q000188:drug therapy; D001145:Arrhythmias, Cardiac / Q000188:drug therapy; D001249:Asthma / Q000188:drug therapy; D002118:Calcium / Q000502:physiology; D015640:Ion Channel Gating; D017202:Myocardial Ischemia / Q000188:drug therapy; D026902:Potassium Channel Blockers; D015221:Potassium Channels / Q000737:chemistry / Q000187:drug effects*; D014549:Urinary Incontinence / Q000188:drug therapy
D026902:Potassium Channel Blockers; D015221:Potassium Channels; D000255:Adenosine Triphosphate; D002118:Calcium